Skip to main content
Skip to content
Case File
sd-10-EFTA01392049Dept. of JusticeOther

EFTA Document EFTA01392049

GLDUS144 Glenn Warren Section 2: Investment Performance Glendower Capital Secondary Opportunities Fund M LP In Exhibit 2 each of SOF. SOF D. SOF II and SOF III is benchinarked against its vintage peer group reported in the Cambridge Associates Secondaries Benchmark statistics (September 30, 2017). The SOF Funds present comparatively strong Net IRR. DPI and TVPI across each vintage year. Exhibit 2: SOF Funds performance versus Cambridge Associates Secondary Fund Benchmark " 34 37 Secondar

Date
Unknown
Source
Dept. of Justice
Reference
sd-10-EFTA01392049
Pages
1
Persons
0
Integrity
Loading PDF viewer...

Summary

GLDUS144 Glenn Warren Section 2: Investment Performance Glendower Capital Secondary Opportunities Fund M LP In Exhibit 2 each of SOF. SOF D. SOF II and SOF III is benchinarked against its vintage peer group reported in the Cambridge Associates Secondaries Benchmark statistics (September 30, 2017). The SOF Funds present comparatively strong Net IRR. DPI and TVPI across each vintage year. Exhibit 2: SOF Funds performance versus Cambridge Associates Secondary Fund Benchmark " 34 37 Secondar

Ask AI About This Document

0Share
PostReddit

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
GLDUS144 Glenn Warren Section 2: Investment Performance Glendower Capital Secondary Opportunities Fund M LP In Exhibit 2 each of SOF. SOF D. SOF II and SOF III is benchinarked against its vintage peer group reported in the Cambridge Associates Secondaries Benchmark statistics (September 30, 2017). The SOF Funds present comparatively strong Net IRR. DPI and TVPI across each vintage year. Exhibit 2: SOF Funds performance versus Cambridge Associates Secondary Fund Benchmark " 34 37 Secondary funds: Net IRR to limited partners Secondary funds: Net multiple to tanned partners sea 10% • claw (mane BC. 1pw .r3d wilt sac 211% a SCEs • 1h.O.le SOF ,,I 13% t i 2* l 10 20% 200. It s t t • t 11t W. 41 • ; 05a n. 0% toe Ivfi I SC DPI • lab 1 a 00 06 14 ! II 04 $5 /6 SOF 0 1V11 DP1.3 I. .50; :TI: I e 111 904 6 I 3.• OH • 0 I . or te *C9 '10 11 12 13 11 ohm OM to* mot r SOF aria ore •C• tedo RYPI In Exhibit 3. each of SOF. SOF D. SOF II and SOF III is benchmarked against its vintage group of top quartile buyout funds reported in the Cambridge Associates Global Buyout Benchmark as of September 30. 2017. Again, the SOF Funds present comparatively strong Net IRR, DPI and TVPI across each vintage year. Exhibit 3: Buyout•hke returns with a secondary risk profiles OPP • 4Y1 ca. or AX4 AN Alt to no n,r X Wee 0. my. 1 • EOF D tt S•1 2n.1 •x tin j • et= y, 1art ant art ".‘„ 0 Some: Cambridge Associates Secondaries Benchmark statistics as of September 30 2017 SOF Funds are shown benchmarked against their VOII100 yew peer group SOF and SOF 0 performance is not included in the data se teed to calculate the benchmark data Note that the performance figures in reaped ci SW and SOF D have not been audited and should be read and rewewed n comma:al with Appendix 5 !ovarian' ParlonnanCe I rakmadon Past pedamance of SOF Finds 6 not a predecton ci Nude performance. Information presented n Exhibt 21s based al the outpaced results of SOF, SOF D. SOF II and SOF III as of September 30. 2017 ,4 Past performance is net a DfeCktell of the Mute performance of SOF, SOF D. SOF II or SOF III tow is included to demonstrate the track record of the Glick:Wow SOF Team There can be no aesurance that SOF ft/ win achieve canpeiade MEd% Ex that any target resultswill be acheved j1 DPI = Prarbutions to Paid-In Capital. RVOI = Residual Value to Paelan Capital. TVPI = Total Value to Paidan Capital '4 Source' Cambridge Associates GOD& Buyout Benchmark as of September 30. 2017. The int ormaeon reflects a comparison of SOF. SOF D. SOF II Et SOF III performance against one benchmark only Past performance is iv a prediction ol the Uwe performance of SOF. SOF D, SOF II. SOF III or any other Glendower rinds and there can be no asswance that SOF W will achieve comparable resifts or that any target results will be achieved. but is included to demonstrate the track record ci the Glendower SOF Team Internam presented in this chart is based on the unaudted issues of SOF. SOF D. 9CF II and SOF III as of Standby 30.2017 and should be read and reviewed in COnprICtOn and should be read and rov'ewed in conjunction with Appendix 5 Impatant Pet nine Information which sets forth amongst other throe important information regarding the perfamance desaited above Confidential Prrvate Placement Memorandum 9 CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0097198 CONFIDENTIAL SDNY_GM_00243382 EFTA01392049

Related Documents (6)

Dept. of JusticeAug 22, 2017

1 May 1 1255-May 6 237_Redacted.pdf

Kristen M. Simkins me: Sent Tn: Subject: Atladimem: LT. THOMAS E. ALLEN JR Thomas S. Allen. Jr. Sunday. May BIL EDIE 12:55 AM Allyson FL Dwell; Brenda McKin1e?c C. Kay Wandring: Caitlyn D. Neff: Daniel?le Minarch?lck: JeFFrey' T. Hite; Jon D. Fisher. Jonathan M. Mfl?n-der. Joseph 5. Kolenorluan Mendez: Kevin T. Jeirles; [any Lidgett Lee R. Shea??er: Lorinda L. Brown.- Matti-new T. Fishet: Melanie Gordan; Michael S. Woods Richard C. 5mm; Shephanie D. Calander?mtus Report SMDIE 20150501004

493p
Dept. of JusticeMar 11, 2011

FBI USAMRID Investigation

011621Anthrax Page 1 of 1446 o I 2792\-WF-222936-'-USAMRIID - \\OC o I [he followijg investigation was conducted by Special Agent (SA)_ _of the federal Bureau of Investigation (FBI) on February 24, 2005: ? The United States Army Medical Research Institute of Infectious Diseases (USAMRIID) Keycard Access records from 1998 through 2002 were queried f r v' ? ? ? scientist nd visitin scient'st both ?rom the who have p eviously been identified as visiting USAMRIID circa May 1998. ;11 available

1446p
Dept. of JusticeAug 22, 2017

15 July 7 2016 - July 17 2016 working progress_Redacted.pdf

Kristen M. Simkins From: Sent: To: Cc: Subject: Irons, Janet < Tuesday, July 12, 2016 10:47 AM Richard C. Smith     Hello Warden Smith,     mother is anxious to hear the results of your inquiry into her daughter's health.   I'd be grateful if you could  email or call me at your earliest convenience.  I'm free today after 2 p.m.  Alternatively, we could meet after the Prison  Board of Inspectors Meeting this coming Thursday.    Best wishes,    Janet Irons    1 Kristen M. Simkins From: Sent:

1196p
Dept. of JusticeMay 26, 2015

Correctional Center RFP

Texas Department of Criminal Justice Brad Livingston Executive Director April 24, 2008 Re: Request for Proposals 696-PF-8-P030, Correctional Centers and/or Lockhart Work Program Facility Services Dear Prospective Offeror: Enclosed for your consideration is the above referenced solicitation for the operation and maintenance of Correctional Centers and/or Lockhart Work Program Facilities. When submitting proposals, please ensure all required information is included. Section of the soli

177p
Dept. of JusticeJun 4, 2021

Amended Complaint: California Sex Trafficking Ring

1 2 3 4 5 6 7 8 9 10 11 12 13 XAVIER BECERRA Attorney General of California JAl\4ES ROOT Senior Assistant Attorney General DIANA CALLAGHAN Supervising Deputy Attorney General AMANDA PLISNER VIKRAM MANDLA Deputy Attorneys General State Bar No. 287101 300 South Spring Street, Suite 1702 Los Angeles, CA 90013 Telephone: (323) 765-2019 Fax: (213) 897-2806 E-mail: [email protected] Attorneys for People of the State of California SUPERIOR COURT OF Tiffi STATE OF CALI

17p
Dept. of JusticeOtherUnknown

EFTA Document EFTA01392208

GL0US144 Glenn Warren Fund Secondaries transactions liustrative case studies -01 Zi Project / Fund Deal Size / Discounts Funds I assets / region Seller Description 15 re .2> Modigliani US$38m 17 funds European • Proprietary deals from family offices redeploying capital away from PE (SOF II) 34% 225 assets Global family offices • Liquidity solution on complex illiquid feeder funds structured to address tax and legal requirements Globally diversified portfolio of mature (8

1p

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.